Project Details
Description
There is little literature related to the characterization of Intermediate Uveitis in South America and Colombia.
Within a literature search, 4 related studies were identified, in which a general epidemiological description of uveitis was carried out: one in Chile, one in Brazil and two in Colombia.
However, there are no studies that describe the specific characteristics in terms of clinical symptoms, treatment and outcomes of patients with intermediate uveitis in our country.
This project seeks to describe the epidemiological, clinical characteristics, treatment and outcomes of patients diagnosed with intermediate uveitis in a center specialized in ocular inflammation in Bogotá, Colombia.
This in order to increase knowledge of this disease and improve its diagnostic and therapeutic approach.
Within a literature search, 4 related studies were identified, in which a general epidemiological description of uveitis was carried out: one in Chile, one in Brazil and two in Colombia.
However, there are no studies that describe the specific characteristics in terms of clinical symptoms, treatment and outcomes of patients with intermediate uveitis in our country.
This project seeks to describe the epidemiological, clinical characteristics, treatment and outcomes of patients diagnosed with intermediate uveitis in a center specialized in ocular inflammation in Bogotá, Colombia.
This in order to increase knowledge of this disease and improve its diagnostic and therapeutic approach.
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/20 → 8/31/21 |
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
Main Funding Source
- Installed Capacity (Academic Unit)
Location
- Bogotá D.C.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.